Inducible nitric oxide synthase (iNOS) can be expressed by many types of mammalian cells in response to diverse signals acting synergistically, including cytokines and microbial products. We previously showed that induction of iNOS in mouse macrophages by interferon 3' (IFN-3') and lipopolysaccharide (LPS) was at the transcriptional levd. From a mouse genomic library, we now cloned a 1,749-bp fragment from the 5'-flanking region of the iNOS gene, and used $1 nuclease mapping and primer extension to identify the mRNA transcription start site within it. The mRNA initiation site is preceded by a TATA box and at least 22 oligonucleotide elements homologous to consensus sequences for the binding of transcription factors involved in the inducibility of other genes by cytokines or bacterial products. These include 10 copies of IFN-3" response dement; 3 copies of 3'-activated site; 2 copies each of nuclear factor-~B, IFN-ot-stimulated response element, activating protein 1, and tumor necrosis factor response element; and one X box. Plasmids in which all or the downstream one half or one third of this region of iNOS were linked to a reporter gene encoding Chloramphenicol acetyitransferase were transfected into cells of the RAW264.7 macrophage-like line. All these constructs conferred inducibility of the iNOS promoter by LPS, but only the construct containing all 1,749 bp conferred synergistic inducibility by IFN-3" plus LPS.
Summary
Inducible nitric oxide synthase (iNOS) can be expressed by many types of mammalian cells in response to diverse signals acting synergistically, including cytokines and microbial products. We previously showed that induction of iNOS in mouse macrophages by interferon 3' (IFN-3') and lipopolysaccharide (LPS) was at the transcriptional levd. From a mouse genomic library, we now cloned a 1,749-bp fragment from the 5'-flanking region of the iNOS gene, and used $1 nuclease mapping and primer extension to identify the mRNA transcription start site within it. The mRNA initiation site is preceded by a TATA box and at least 22 oligonucleotide elements homologous to consensus sequences for the binding of transcription factors involved in the inducibility of other genes by cytokines or bacterial products. These include 10 copies of IFN-3" response dement; 3 copies of 3'-activated site; 2 copies each of nuclear factor-~B, IFN-ot-stimulated response element, activating protein 1, and tumor necrosis factor response element; and one X box. Plasmids in which all or the downstream one half or one third of this region of iNOS were linked to a reporter gene encoding Chloramphenicol acetyitransferase were transfected into cells of the RAW264.7 macrophage-like line. All these constructs conferred inducibility of the iNOS promoter by LPS, but only the construct containing all 1,749 bp conferred synergistic inducibility by IFN-3" plus LPS.
N
'itric oxide (NO), a short-lived, radical gas, acts as an intercellular messenger in most or all mammalian organs, participating in vascular homeostasis, neurotransmission, and antimicrobial defense (1) . Three genes encode NO synthases (NOS) of two biochemical types. Neuronal and endothelial NOS are constitutive but dormant until activated briefly by Ca 2+ transients that sustain the binding of calmodulin. These have been termed cNOS (1) . A third NOS is expressed only after transcriptional induction (2) . Once synthesized, this NOS is active for prolonged periods, perhaps because it binds calmodulin without a requirement for elevation of Ca 2+ above the levels in resting ceils (3) . Termed inducible NOS (iNOS), the latter form of the enzyme has been purified (4-6) and cloned (2, 7, 8) from mouse macrophages, iNOS mediates some of the cytotoxic action of activated macrophages, and when expressed in vascular smooth muscle, endothdium and/or liver, may play a key role in septic shock (9) .
Three considerations have focused our interest on the iNOS promoter. First, immunologically inducible, high-output NO production is widely distributed, having been observed not only in macrophages, endothelium, vascular smooth muscle, and hepatocytes, but also in tumor cells, fibroblasts, mesangial cells, astrocytes, keratinocytes, and cardiac myocytes (1, (10) (11) (12) . Second, in all these cells, maximal induction of iNOS depends on synergistic combinations of stimuli, the most effective ones varying with the cell type. For mouse macrophages, synergistic inductive combinations include IFN-3', IFN-cr or IFN-B plus LPS, or IFN-3' plus TNF-oe or -lJ (13) (14) (15) (16) , whereas for rat and human hepatocytes, four signals are required: IFN-3', TNF-oe, IL-1/L and LPS (17) . Finally, iNOS is subject to immunologic suppression, for example, by TGF-B (18), macrophage deactivation factor (18) , and IL-4 (19) . We have taken steps toward analyzing the molecular mechanisms by which iNOS is induced and suppressed, by cloning the promoter of the mouse iNOS gene, and distinguishing regions within it that are responsive to LPS alone or to the synergistic contribution of IFN-3'.
Materials and Methods
Materials. Recombinant marine IFN-3, (5 x l& U/ml) was generously provided by Genentech (South San Francisco, CA Cloning of 5'-Flanking Region from iNOS. The 5'-fragment of iNOS eDNA (nucleotides 1-845, see reference 2), comprised of 255 bp of 5'-untranslated region and 590 bp of NI-I2-terminal coding region, was isolated from the clones described (2). This fragment served as a template to prepare a DNA probe for screening 20,000 cosmid colonies from a mouse genomic library provided byJ. Mudgett (Merck Research Laboratories, Rahway, NJ). A positive clone was selected and its genomic DNA was digested by HinclI. The products were subjected to Southern blot with a second DNA probe prepared from only the 5'-untranslated region of iNOS (nucleotides 1-200, see reference 2). A unique fragment of 1.7 kb hybridized and was subcloned into pBluescript SK+ at the HinclI site to form pUP1 and pUPlr (in the two orientations). These plasmids were used to sequence the 1,749-bp insert (-1588 to +161) by the dideoxy method (20) .
Constructs of iNOS Promoter Fused with Chloramphenicol Acetyltrans-
)'erase (CAT) Gene. The 1,749-bp fragment of the 5'-flanking region of iNO$ was excised from plasmid pUP1 and inserted, with the same orientation, into pCAT-Basic (Promega Corp.) upstream of the promoterless CAT gene to form the construct pliNOS-CAT. Portions were removed from pliNOS-CAT to form p2iNOS-CAT, p3iNOS-CAT, and p5iNOS-CAT, as specified below.
Initiation Site for mRNA. This was determined by $1 nuclease mapping with a single-stranded, end-labded DNA probe (21) and by primer extension (22) with the following modifications: (a) the primer and KNA template were hybridized in buffer without formamide at 65~ for 2 h; and (b) avian myeloblastosis virus reverse transcriptase was used.
Transient Transfection of RAW264.7 Cells and CAT Assays. RAW
264.7 cells were transfected by a modification of the DEAE-dextran procedure (23) . After cells were washed twice with RPMI, 10/~g of plasmid DNA was added per I0 r cells in 1 ml of RPMI without serum prewarmed to 37~ and containing DEAE-dextran (250 /~g/ml) and 50 mM Tris (pH 7.4). The suspension was incubated at 37~ for 45-60 rain followed by a l-rain shock with 10% DMSO at room temperature. The cells were washed, distributed to 100-ram plates, each with about 5 x 106 cells in 10 ml of complete medium, and incubated at 37~ in 5% CO2. At least 24 h later, the medium was changed, and IFN-~/and/or LPS were added to some plates. About 14 h later, the cells were washed with ice-cold PBS, resuspended in 0.25 mM Tris (pH 7.8), and subjected to three cycles of freezing and thawing. Lysates were centrifuged (11,700 g for 10 min at 4~ The supernatant was heated at 65~ for 10 rain to inactivate CAT inhibitors and then centrifuged as above. The supernatant was assayed for CAT activity by TIC method (24) . Protein content was determined as described by Bradford (25) .
Results

Cloning and Analysis of a 1,749-bp Y-Flanking Region of
iNOS. A 1,749-bp HinclI fragment at the 5'-flanking region of iNOS was cloned from a mouse genomic library and sequenced ( Fig. 1 A) . Both $1 nuclease mapping and primer extension (Fig. 2) identified the same initiation site (designated +1 in Fig. 1 A) 30 bp downstream of a TATA box. The TATA box is preceded by a multitude of oligonucleotide elements homologous to consensus sequences for binding of transcription factors involved in cytokine or LPS induction of other genes, including sequences specified as IFN-y response element (~/-IRE) (10 copies) (26, 27) ; ~/-activated site (GAS) (3 copies) (26, 28) ; nuclear factor-gB (NF-r,B) (2 copies) (29); IFN-c~-stimulated response element (ISRE) (2 copies) (28); activator protein 1 (AP-1) (2 copies) (30); TNF response element (TNF-RE) (2 copies) (31); and X box (1 copy) (26, 32) . $1 nuclease mapping and primer extension (Fig. 2) reinforced the previous conclusion (2) that no detectable mKNA for iNOS accumulates in RAW 264. (Table 1 and Fig. 3) . By itself, LPS induced promoter activity in a concentrationdependent manner. IFN-3' alone was ineffective. However, IFN-3, synergistically enhanced the response to LPS (Fig. 4 A) .
Downstream portions of the 1,749-bp region were linked to the CAT gene to form the constructs p2iNOS-CAT and p3iNOS-CAT (Fig. 1 B) . Both conferred inducibility by LPS in a concentration-dependent fashion. However, in contrast to pliNOS-CAT, the constructs lacking the upstream half of the 1,749-bp fragment did not respond to the addition of IFN-y (Fig. 4 , B and C). $1 nuclease mapping confirmed that the mKNA initiation site of the CAT transcript in the cells transfected with pliNOS-CAT was at the same location as that for iNOS transcript itself in untransfected cells, and that no detectable CAT mKNA synthesis was initiated in transfected ceils without induction by IFN-y and LPS (data not shown).
Discussion
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t CAT activity in each transfectant is expressed as percent acetylation of chloramphenicol when 4 #g cell lysate protein was assayed at 37~ for 2 h (mean + SEM).
The critical contribution of the upstream portion for responsiveness to IFN-'), may relate to its content of four ~/-IRE, all of which match the consensus sequence perfectly (8/8) . By contrast, the downstream half of the 1,749-bp fragment contains six ',/-IRE, but each matches the consensus sequence less well (7/8). The upstream half also contains two ISRE lacking from the downstream half; two GAS (11/15, 8/10) versus one (7/10) . CAT activity was measured as described in Table 1 . In each panel, all treatments were carried out with cells from the same transfected pool. 1 and 3) or presence (lanes 2 and 4) of IFN-31 (50 U/ml) and LPS (1 #g/ml). Cell lysates were then assayed for CAT and the ethyl acetate extract of the reaction mixture subjected to TLC followed by autoradiography.
RAW 264.7 macrophage-like cells have been a useful tool for transfection with reporter constructs to demonstrate promoter activity in genes that are inducible in macrophages (34, 35) . Both RAW 264.7 cells (2, 4, 13) and primary macrophages (14-16) produce iNOS when treated with combinations of cytokines and LPS. However, RAW 264.7 cells do not perfectly mirror the patterns of induction seen with primary mouse peritoneal macrophages. RAW 264.7 cells produce NO after exposure to LPS alone (13), whereas primary mouse peritoneal macrophages do so little or not at all (15) . Conversely, primary mouse peritoneal macrophages respond to IFN-'), alone by producing NO (15), but early passage RAW 264.7 cells do not (our unpublished observations). Thus, a full analysis of synergistic induction and suppression of/NOS will require transfection of promoter-reporter constructs into additional cell types, including primary macrophages.
Perhaps the best understood example of transcriptional induction by IFN-3/involves a primary response gene coding for a guanylate binding protein of unknown function (28, 36, 37) . The GAS in the guanylate binding protein promoter binds a 91-kD protein termed ")'-activated factor (GAF). GAF has recently been cloned by virtue of its participation in the heterotetrameric transcription complex activated by IFN-cz (38) . After treatment of human fibroblast FS2 cells with either IFN-3, or IFN-c~, GAF is phosphorylated on tyrosine and translocates to the nucleus (39) . Our preliminary experiments (data not shown) suggest that tyrosine phosphorylation may also participate in the induction of iNOS. GAF or a similar protein may undergo IFN-3,-induced tyrosine phosphorylation in the cytoplasm, translocate to the nucleus, and induce the expression of a transcription factor that binds the iNOS promoter. LPS may synergize with IFN-q/by augmenting this pathway, or by activating or inducing a distinct transcription factor(s) that may cooperate with proteins that bind the iNOS promoter in response to IFN-% We thank J. Mudgett (Merck Research Laboratories) for the mouse genomic library and information on intron 1; M. Tocci, A. Ding, and M. Fuortes for review of the manuscript; J. Schmidt and P. Davies for advice; Genentech, Inc. for recombinant mouse IFN-3r; and T. Troso for technical assistance during screening of the genomic library.
